Zeinab Ghesmati

678 total citations · 2 hit papers
7 papers, 436 citations indexed

About

Zeinab Ghesmati is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Zeinab Ghesmati has authored 7 papers receiving a total of 436 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Genetics. Recurrent topics in Zeinab Ghesmati's work include Cancer, Hypoxia, and Metabolism (2 papers), Enzyme Production and Characterization (1 paper) and Enzyme Catalysis and Immobilization (1 paper). Zeinab Ghesmati is often cited by papers focused on Cancer, Hypoxia, and Metabolism (2 papers), Enzyme Production and Characterization (1 paper) and Enzyme Catalysis and Immobilization (1 paper). Zeinab Ghesmati collaborates with scholars based in Iran, Nigeria and Germany. Zeinab Ghesmati's co-authors include Mehdi Sabzichi, Fatemeh Ramezani, Behzad Baradaran, Ommoleila Molavi, Mortaza Taheri‐Anganeh, Ahmad Movahedpour, Omid Vakili, Hassan Ghasemi, Seyyed Hossein Khatami and Shabnam Fayezi and has published in prestigious journals such as Gene, Reviews in Endocrine and Metabolic Disorders and Future Oncology.

In The Last Decade

Zeinab Ghesmati

6 papers receiving 433 citations

Hit Papers

Up-down regulation of HIF-1α in cancer progression 2021 2026 2022 2024 2021 2022 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zeinab Ghesmati Iran 5 187 112 89 84 48 7 436
Hossam Murad Syria 13 196 1.0× 58 0.5× 49 0.6× 41 0.5× 24 0.5× 38 534
Dengke Li China 16 369 2.0× 97 0.9× 137 1.5× 65 0.8× 14 0.3× 57 646
Hairuszah Ithnin Malaysia 14 206 1.1× 48 0.4× 98 1.1× 22 0.3× 26 0.5× 22 522
Hua Qiu China 8 368 2.0× 64 0.6× 30 0.3× 119 1.4× 17 0.4× 20 626
Zhengyu Huang China 16 249 1.3× 48 0.4× 216 2.4× 30 0.4× 19 0.4× 60 719
Xiaobo Xu China 14 298 1.6× 123 1.1× 35 0.4× 37 0.4× 43 0.9× 28 551
Song Wu China 12 329 1.8× 59 0.5× 144 1.6× 45 0.5× 18 0.4× 34 625
Qingqing Gu China 16 387 2.1× 81 0.7× 160 1.8× 15 0.2× 19 0.4× 65 823
Chun‐Yao Yang Taiwan 15 199 1.1× 56 0.5× 59 0.7× 70 0.8× 12 0.3× 25 566
So‐Young Chun South Korea 16 263 1.4× 49 0.4× 77 0.9× 16 0.2× 16 0.3× 34 634

Countries citing papers authored by Zeinab Ghesmati

Since Specialization
Citations

This map shows the geographic impact of Zeinab Ghesmati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zeinab Ghesmati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zeinab Ghesmati more than expected).

Fields of papers citing papers by Zeinab Ghesmati

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zeinab Ghesmati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zeinab Ghesmati. The network helps show where Zeinab Ghesmati may publish in the future.

Co-authorship network of co-authors of Zeinab Ghesmati

This figure shows the co-authorship network connecting the top 25 collaborators of Zeinab Ghesmati. A scholar is included among the top collaborators of Zeinab Ghesmati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zeinab Ghesmati. Zeinab Ghesmati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
2.
Ghesmati, Zeinab, et al.. (2023). An update on the secretory functions of brown, white, and beige adipose tissue: Towards therapeutic applications. Reviews in Endocrine and Metabolic Disorders. 25(2). 279–308. 53 indexed citations
3.
Ghesmati, Zeinab, Mortaza Taheri‐Anganeh, Khadijeh Ahmadi, et al.. (2022). Designing a humanized immunotoxin based on DELTA-stichotoxin-Hmg2a toxin: an in silico study. Journal of Molecular Modeling. 28(12). 392–392. 1 indexed citations
4.
Khatami, Seyyed Hossein, Omid Vakili, Ahmad Movahedpour, et al.. (2022). Laccase: Various types and applications. Biotechnology and Applied Biochemistry. 69(6). 2658–2672. 120 indexed citations breakdown →
5.
Goradel, Nasser Hashemi, et al.. (2021). Oncolytic Virotherapy as Promising Immunotherapy Against Cancer: Mechanisms of Resistance to Oncolytic Viruses. Future Oncology. 18(2). 245–259. 23 indexed citations
6.
Baradaran, Behzad, et al.. (2021). Up-down regulation of HIF-1α in cancer progression. Gene. 798. 145796–145796. 190 indexed citations breakdown →
7.
Movahedpour, Ahmad, Nahid Ahmadi, Zeinab Ghesmati, et al.. (2021). β‐Galactosidase: From its source and applications to its recombinant form. Biotechnology and Applied Biochemistry. 69(2). 612–628. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026